poisar

Stocks · News reference

Parabilis Medicines Q2 EPS $(2.32) Misses $(0.08) Estimate, Sales $148.000K Miss $25.000M Estimate

Aug 13, 2026, 11:29 AMBenzinga Newsdesk

Parabilis Medicines (NASDAQ:PBLS) reported quarterly losses of $(2.32) per share which missed the analyst consensus estimate of $(0.08) by 2800 percent. This is a 89.59 percent increase over losses of $(22.28) per share

Read original sourceMore stocks news

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

PBLS
Source
benzinga
Observed
Aug 13, 2026, 11:29 AM
Checked
Aug 13, 2026, 11:29 AM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Aug 25, 2026, 8:10 PMSEC EDGAR

    8-K filing — Parabilis Medicines, Inc. (PBLS)

    Filed: 2026-08-25 AccNo: 0001193125-26-365132 Size: 310 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

    Read original at edgar
    PBLS